MARKET

AGEN

AGEN

Agenus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.780
-0.060
-1.56%
After Hours: 3.780 0 0.00% 16:00 01/24 EST
OPEN
3.860
PREV CLOSE
3.840
HIGH
3.918
LOW
3.730
VOLUME
642.63K
TURNOVER
--
52 WEEK HIGH
4.570
52 WEEK LOW
2.135
MARKET CAP
519.23M
P/E (TTM)
-3.8552
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AGEN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AGEN News

  • Did You Manage To Avoid Agenus's (NASDAQ:AGEN) 22% Share Price Drop?
  • Simply Wall St..01/17 10:12
  • Agenus Announces the Appointment of Dr. Jennifer Buell to the position of President and COO
  • PR Newswire.01/09 15:59
  • Agenus Initiates Phase I Study on Oncology Candidate AGEN1223
  • Zacks.01/09 14:48
  • Amicus (FOLD) Provides Updates on AT-GAA for Pompe Disease
  • Zacks.01/08 15:04

More

Industry

Biotechnology & Medical Research
-2.64%
Pharmaceuticals & Medical Research
-2.00%

Hot Stocks

Name
Price
%Change

About AGEN

Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs; vaccine programs, including Prophage, AutoSynVax and PhosPhoSynVax, and saponin-based vaccine adjuvants, principally QS-21 Stimulon adjuvant (QS-21 Stimulon). The Company's discovery pipeline includes a range of checkpoint modulating (CPM) antibodies. The Company's vaccine platforms include its heat shock protein (HSP)-based Prophage vaccine candidates, and its synthetic vaccine candidates, ASV and PSV.
More

Webull offers Agenus Inc (AGEN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.